Punita Kumar-Sinha appointed Independent Director at Aurobindo Pharma USA
Seasoned governance expert and board leader brings extensive experience in strategic oversight, risk management, and corporate governance across multiple sectors
Seasoned governance expert and board leader brings extensive experience in strategic oversight, risk management, and corporate governance across multiple sectors
The newly commissioned facility strengthens the ’company’s capabilities in the development and manufacturing of generic and complex sterile injectable products
The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
Seasoned pharma leader recognized for driving sales excellence, marketing strategy, and business growth
Exclusive partnership to expand access to high-quality seamless anodized aluminium packaging for sterile APIs and pharmaceutical products across India.
Approval for generic version of Xeljanz enables immediate launch and strengthens Aurobindo’s U.S. portfolio with its 586th ANDA approval
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
Anbalagan has led end-to-end product development programs from concept to commercialization, with a strong focus on regulatory compliance, process scalability, and manufacturing readiness
Chennai based Bioneemtec India has received support from Technology Development Board for commercializing indigenous green chemistry technologies to produce critical pharmaceutical ingredients
Subscribe To Our Newsletter & Stay Updated